CRISPR Therapeutics AG

CRSP · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
200
SEC Filings

Business Summary

CRISPR Therapeutics AG is a biopharmaceutical company focused on developing CRISPR/Cas9-based gene editing therapeutics. Its lead product, CASGEVY (exagamglogene autotemcel), received the world's first approval of a CRISPR-based therapy in 2023 for sickle cell disease and transfusion-dependent beta thalassemia, developed in collaboration with Vertex Pharmaceuticals. The company also pursues in vivo editing, allogeneic CAR T cell therapies for autoimmune and oncology indications, and regenerative medicine programs.

Next Earnings

Q2 FY2026 — expected 2026-08-04

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCRSPdiscussed_in_filing Healthcare & Bio
topic_mentionCRSPdiscussed_in_filing Platform & Ecosystem
topic_mentionCRSPdiscussed_in_filing Healthcare & Bio
topic_mentionCRSPdiscussed_in_filing Platform & Ecosystem
topic_mentionCRSPdiscussed_in_filing Healthcare & Bio
topic_mentionCRSPdiscussed_in_filing Platform & Ecosystem
topic_mentionCRSPdiscussed_in_filing Healthcare & Bio
topic_mentionCRSPdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001193125-26-048957EDGAR125K words
2025-02-112024-12-310000950170-25-017899EDGAR—
2024-02-212023-12-310000950170-24-017571EDGAR—
2023-02-212022-12-310000950170-23-003441EDGAR—
2022-02-152021-12-310000950170-22-001282EDGAR—
2021-02-162020-12-310001564590-21-006074EDGAR—
2020-02-122019-12-310001564590-20-004355EDGAR—
2019-02-252018-12-310001564590-19-004115EDGAR—
2018-03-082017-12-310001564590-18-004920EDGAR—
2017-03-102016-12-310001564590-17-003977EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-273337EDGAR28K words
2025-08-042025-06-300000950170-25-102052EDGAR—
2025-05-062025-03-310000950170-25-064468EDGAR—
2024-11-052024-09-300000950170-24-121105EDGAR—
2024-08-052024-06-300000950170-24-090746EDGAR—
2024-05-082024-03-310000950170-24-055719EDGAR—
2023-11-062023-09-300000950170-23-059476EDGAR—
2023-08-072023-06-300000950170-23-039075EDGAR—
2023-05-082023-03-310000950170-23-018811EDGAR—
2022-11-012022-09-300000950170-22-020845EDGAR—
2022-08-082022-06-300000950170-22-015256EDGAR—
2022-05-092022-03-310000950170-22-008495EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-160001193125-26-108333EDGAR55K words
2026-03-110001193125-26-101073EDGAR—
2026-02-120001193125-26-048873EDGAR—
2026-01-120001193125-26-009880EDGAR—
2025-11-100001193125-25-273329EDGAR—
2025-10-150001193125-25-240282EDGAR—
2025-08-040000950170-25-102027EDGAR—
2025-06-260000950170-25-090170EDGAR—
2025-06-090000950170-25-083799EDGAR—
2025-05-190000950170-25-074428EDGAR—

200 total filings indexed. 168 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Tags

hemoglobinopathies-(sickle-cell-disease,-transfusion-dependent-beta-thalassemia) oncology-(car-t-cell-therapies) autoimmune-diseases-(car-t-cell-therapies) regenerative-medicine in-vivo-gene-editing-for-common-and-rare-diseases crispr/cas9-gene-editing ex-vivo-cell-editing in-vivo-gene-editing sirna allogeneic-car-t-cell-therapy

Company Identity

CIK0001674416
TickerCRSP
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedV8

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 712e24d573791e28255d1f02bb84ebec91f9fc92be5759b4dfabf47bb829ef36
parent: 95d8ee3831d8dcef806ed06705743bc3d24bcf1fd44150ba186aee52c12f3563
content hash: 084fa0b9b12e136a80ba8eda17a3af7e6aa0f53ae1348e8d8955f668b49b88c9
signed: 2026-04-13T04:44:30.254Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf